All Stories

  1. Clinical predictors and outcome implications of early readmission in lung transplant recipients
  2. Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival
  3. Gastroesophageal Reflux Disease Symptom Correlation with Ambulatory PH-Metry and Esophageal High Resolution Manometry in Lung Transplant Candidates
  4. Predictors of Survival in Lung Transplant Recipients Requiring Post-Operative ECMO: First National Analysis
  5. Impact of Diabetes Mellitus and Glycemic Control in Lung Transplant Donors on Recipient Survival
  6. The Impact of Intravenous Immunoglobulin in Sensitized Lung Transplant Recipients with a cPRA <25%
  7. Simultaneous Heart-Kidney Transplantation Is Superior to Sequential Heart-Kidney Transplantation in Renal Failure Heart Transplant Candidates
  8. Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer
  9. Surgery Versus Optimal Medical Management for N1 Small Cell Lung Cancer
  10. Transplant size mismatch in restrictive lung disease
  11. Adverse outcomes associated with postoperative atrial arrhythmias after lung transplantation: A meta-analysis and systematic review of the literature
  12. The wait for the waitlist: The next challenge in the lung allocation system
  13. Extracorporeal membrane oxygenation in the pre and post lung transplant period
  14. P3.07-012 Disparities in Guideline-Concordant Treatment for Node-positive Non-Small Cell Lung Cancer Following Surgery
  15. The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates
  16. Spontaneously Breathing Extracorporeal Membrane Oxygenation Support Provides the Optimal Bridge to Lung Transplantation
  17. Patient Preferences in Treatment Choices for Early-Stage Lung Cancer
  18. Postoperative Critical Care of Lung Transplant Patients
  19. Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma
  20. Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer
  21. Safety of hyperbaric oxygen therapy for management of central airway stenosis after lung transplant
  22. Staging of Bilateral Lung Transplantation for High-Risk Patients With Interstitial Lung Disease: One Lung at a Time
  23. Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality
  24. Intravenous Immunoglobulin in Sensitized Lung Transplant Recipients and Early Outcomes
  25. Lung transplantation at Duke
  26. Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer
  27. Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials
  28. Impact of donor and recipient hepatitis C status in lung transplantation
  29. Sublobar Resection for Clinical Stage IA Non–small-cell Lung Cancer in the United States
  30. The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer
  31. Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer
  32. Adjuvant Chemotherapy After Lobectomy for T1–2N0 Non–Small Cell Lung Cancer: Are the Guidelines Supported?
  33. Survival After Lung Transplant in Alpha-1-Antitrypsin Deficiency Recipients Compared to Other Forms of Chronic Obstructive Pulmonary Disease
  34. Factors Predicting Survival in Early Lung Retransplantation
  35. Single-lung transplantation in the United States: What happens to the other lung?
  36. The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation
  37. Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer
  38. Lung Transplantation Procedure and Surgical Technique
  39. Cromolyn ameliorates acute and chronic injury in a rat lung transplant model
  40. Perioperative Venous Thromboembolism Prophylaxis in Lung Transplant Patients
  41. Is a Priori Staging of Bilateral Lung Transplant the Optimal Surgical Approach for High-risk Patients With Interstitial Lung Disease?
  42. Donor Diabetes and Lung Transplant: Does It Matter?
  43. Donor and Recipient Hepatitis C Status in Lung Transplant
  44. Bilateral Sequential Lung Transplantation
  45. Prophylactic Antireflux Surgery in Lung Transplantation
  46. Extracorporeal membrane oxygenation post lung transplantation
  47. Coronary Revascularization in Lung Transplant Recipients With Concomitant Coronary Artery Disease
  48. Bridging to Lung Transplant: What Method and for Whom?
  49. Su2130 Outcomes of Lung Transplant Patients With Severe GI Complications
  50. Optimizing the Estimation of Renal Function in Lung Transplant Candidates
  51. Utility of Six-Minute Walk Distance in Predicting Outcomes after Lung Transplant: A Nationwide Survival Analysis
  52. Clinical Predictors and Outcome Implications of 30-Day Hospital Readmission in Lung Transplant Recipients
  53. A simplified technique for pulmonary artery aneurysm repair in a lung transplant recipient with right ventricular outflow tract obstruction
  54. Gastroesophageal reflux disease-induced aspiration injury following lung transplantation
  55. Reply
  56. 87 Coronary Revascularization in Lung Transplant Recipients with Concomitant Coronary Artery Disease
  57. Thoracoscopic Lobectomy: The Gold Standard for Early-Stage Lung Cancer?
  58. Multiseptate Gallbladder
  59. Rabbit Anti-thymocyte Globulin Induction Therapy Does Not Prolong Survival After Lung Transplantation
  60. Cytokine Gene Polymorphisms Are Not Associated With Bronchiolitis Obliterans Syndrome or Survival After Lung Transplant
  61. Role of Flow Cytometry to Define Unacceptable HLA Antigens in Lung Transplant Recipients with HLA-Specific Antibodies
  62. Successful Bilateral Lung Transplant Outcomes in Recipients 61 Years of Age and Older
  63. Nonalloimmune mechanisms contributing to lung allograft dysfunction: a potential role for gastroesophageal reflux disease
  64. Utility of Peritransplant and Rescue Intravenous Immunoglobulin and Extracorporeal Immunoadsorption in Lung Transplant Recipients Sensitized to HLA Antigens
  65. Differences in survival and de novo anti-donor antibody development among lung transplant recipients presensitized to third party class I and class II HLA antigens
  66. Surgical considerations in lung transplantation: transplant operation and early postoperative management
  67. Role of flow cytometry to define donors with unacceptable HLA antigens for sensitized lung transplant candidates
  68. Perioperative desensitization therapy decreases acute rejection in sensitized lung transplant recipients
  69. Non-alloimmune injury mediated by gastroesophageal reflux precipitates alloimmune injury in lung transplant patients
  70. Role of flow cytometry to exclude unacceptable HLA antigens in lung transplant recipients with anti-HLA antibodies
  71. Neoadjuvant Chemoradiation for Rectal Cancer: Analysis of Clinical Outcomes From a 13-Year Institutional Experience
  72. Novel alterations of the adaptor protein Crkl in lung cancer